Stephanie Bonynge
Acute Care · Shelby Township, MINPI 1760957104
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 216 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$856
- Novartis$589
- Abbott$386
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$360
- Kestra Medical Technology Services, Inc.$251
- Boston Scientific$249
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,221100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 53 | $856 |
| Novartis | 36 | $589 |
| Abbott | 5 | $386 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $360 |
| Kestra Medical Technology Services, Inc. | 8 | $251 |
| Boston Scientific | 8 | $249 |
| AstraZeneca | 17 | $236 |
| Johnson & Johnson | 7 | $122 |
| Merck | 6 | $112 |
| Alnylam Pharmaceuticals Inc. | 6 | $106 |
| Lexicon Pharmaceuticals, Inc. | 5 | $97 |
| Pfizer | 5 | $94 |
| Scpharmaceuticals Inc. | 5 | $92 |
| Bayer | 5 | $80 |
| Amarin Pharma, Inc. | 5 | $77 |
| E.r. Squibb & Sons, L.L.C. | 4 | $75 |
| Esperion Therapeutics, Inc. | 3 | $48 |
| Chiesi USA, Inc. | 2 | $44 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Novo Nordisk | 2 | $39 |
| Medtronic | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Avinger Inc. | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Cordis US CORP. | 1 | $22 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Abiomed | 1 | $17 |
| Angiodynamics, Inc. | 1 | $16 |
| Medicomp Inc | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,235 in reported general payments places this provider in the 95th percentile of 567 acute care providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 47 | $57,894 |
| EliquisApixaban | 27 | $39,772 |
| Repatha SureclickEvolocumab | 12 | $7,663 |
| Ranolazine ErRanolazine | 28 | $2,012 |
| Metoprolol Succinate | 105 | $1,935 |
| Rosuvastatin Calcium | 62 | $1,469 |
| ClopidogrelClopidogrel Bisulfate | 58 | $1,424 |
| Nifedipine ErNifedipine | 23 | $1,346 |
| Amiodarone Hcl | 35 | $1,029 |
| Atorvastatin Calcium | 50 | $814 |
| Carvedilol | 47 | $538 |
| Losartan Potassium | 44 | $499 |
| Amlodipine Besylate | 61 | $488 |
| Furosemide | 66 | $474 |
| Olmesartan Medoxomil | 18 | $445 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $122 | $57,89447 claims |
| PfizerEliquis | $94 | $39,77227 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 567 acute care providers in Michigan.
Other acute care in Shelby Township
- Janet WymanDetroit$103K
- Stephanie Mellon ReppenDetroit$57K
- Ashley WozniakLivonia$26K
- Julia BriggsBirch Run$16K
- Candise LovePort Huron$14K
- Janette GuertinPort Huron$14K
- Gregory AliNovi$13K
- Andrew PalmerLansing$9K
- Angela BrennanDearborn Heights$7K
- Jennifer RutzenLansing$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.